BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23634557)

  • 1. [Subcutaneous administration of MabThera for therapy of non-Hodgkin lymphomas frees patients and medical personnel].
    Pflege Z; 2013 Apr; 66(4):253. PubMed ID: 23634557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-Hodgkin lymphoma becomes curable].
    Krankenpfl J; 2005; 43(1-3):40-1. PubMed ID: 15912832
    [No Abstract]   [Full Text] [Related]  

  • 3. [Maintenance therapy with rituximab].
    Krankenpfl J; 2005; 43(7-10):222-4. PubMed ID: 16515293
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab faster infusion for patients with non-Hodgkin's lymphoma in the United States: implications for nursing practice.
    Dawson K
    J Infus Nurs; 2013; 36(3):172-8. PubMed ID: 23558916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Dreyling M
    Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subcutaneous Rituximab is effective and safe].
    Häckel A
    Med Monatsschr Pharm; 2014 Jan; 37(1):39-40. PubMed ID: 24490439
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituxan: the new kid on the block.
    Jonas C
    Oncol Nurs Forum; 1998 May; 25(4):669. PubMed ID: 9599347
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma.
    Eur J Cancer Care (Engl); 2003 Dec; 12(4):306-7. PubMed ID: 14982308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of the lymphomas.
    Lacher MJ
    Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab by subcutaneous route.
    Solal-Celigny P
    Expert Rev Hematol; 2015 Apr; 8(2):147-53. PubMed ID: 25749209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present management of the lymphomas.
    Kabakow B
    Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():39-45. PubMed ID: 4950557
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab Faster Infusion for Patients With Non-Hodgkin's Lymphoma in the United States: Implications for Nursing Practice.
    Dawson K
    J Infus Nurs; 2015; 38 Suppl 6():S4-S10. PubMed ID: 26536411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom.
    Rule S; Collins GP; Samanta K
    J Med Econ; 2014 Jul; 17(7):459-68. PubMed ID: 24720836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma.
    Quéreux G; Brocard A; Peuvrel L; Nguyen JM; Knol AC; Dréno B
    Acta Derm Venereol; 2011 Sep; 91(5):562-7. PubMed ID: 21629975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era.
    Mounier N; Gisselbrecht C
    Curr Opin Oncol; 2011 Mar; 23(2):209-13. PubMed ID: 21169834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
    Czuczman MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan].
    Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Tamaki Y; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N
    Rinsho Ketsueki; 2012 Mar; 53(3):329-36. PubMed ID: 22499050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.